Skip to main content
. 2022 Feb 28;14:829232. doi: 10.3389/fnagi.2022.829232

FIGURE 1.

FIGURE 1

Comparison of p62 immunostaining in the temporal cortex of patients with Alzheimer’s disease (AD) and normal control. (A,B) There is higher p62 immunostaining intensity in AD (A) compared with normal control (B). Scale bar: 100 μm. (C) Quantification of p62 immunostaining intensity based on average p62 mean optical density (MOD) in AD and normal control brains. Data were analyzed as median ± interquartile range from each subject (n = 5) using Mann-Whitney U-test. *p < 0.05.